Loading...

OptimizeRx Corporation

OPRXNASDAQ
Healthcare
Medical - Healthcare Information Services
$6.43
$0.02(0.31%)
U.S. Market opens in 44h 12m

OptimizeRx Corporation (OPRX) Stock Overview

Explore OptimizeRx Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap120.6M
P/E Ratio23.38
EPS (TTM)$0.27
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$7.40
3 Months$7.33
1 Year Target$14.94

OPRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of OptimizeRx Corporation (OPRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.38 and a market capitalization of 120.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.31%
5-Day Change
-4.60%
1-Month Change
-5.16%
3-Month Change
-46.06%
6-Month Change
-70.34%
Year-to-Date (YTD) Change
-47.55%
1-Year Change
-23.27%
3-Year Change
-58.86%
5-Year Change
-87.43%
All-Time (Max) Change
-82.14%

Contact Information

248 651 6568
400 Water Street, Waltham, MI, 48307

Company Facts

128 Employees
IPO DateNov 28, 2007
CountryUS
Actively Trading

Frequently Asked Questions